Spoken Alpha
CapsoVision, Inc
CapsoVision designs and manufactures ingestible capsule endoscopy systems for visualizing the gastrointestinal tract and detecting abnormalities. The company's primary product, CapsoCam Plus, captures panoramic video of the small bowel and is sold to gastroenterologists and hospitals in the U.S. and internationally.
CapsoVision, Inc is a Healthcare company operating in Medical Devices with a $326.3M market cap.
CV missed consensus EPS by 0.2% in Q2 FY2026, reported Aug 12, 2026.
Behavioral analysis
Disclosures
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CV.
$ curl https://api.spokenalpha.com/v1/companies/CVFAQ
Spoken Alpha indexes CV's earnings call transcripts at https://spokenalpha.com/companies/CV. Each call links to attributed speakers and parsed analyst Q&A.
CapsoVision, Inc (CV) held its most recent earnings call on 2026-08-13, covering fiscal Q2 2026.
CapsoVision, Inc (CV) operates in the Healthcare sector (Medical Devices industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-12 | $-0.15 | $-0.13 | -15.4% | $3.6M | — | — | EODHD |
| Q1 FY2026 | 2026-05-13 | $-0.15 | $-0.13 | -15.4% | $2.8M | — | — | EODHD |
| Q4 FY2025 | 2026-03-25 | $-0.16 | $-0.14 | -12.7% | $3.9M | — | — | EODHD |
| Q3 FY2025 | 2025-11-12 | $-0.17 | $-0.12 | -41.7% | $3.5M | — | — | EODHD |
| Q2 FY2025 | 2025-08-13 | $-0.10 | $-0.11 | +9.1% | $3.3M | — | — | EODHD |
| Q1 FY2025 | 2025-05-27 | $-2.49 | $0.00 | — | $2.8M | — | — | EODHD |
Source: EODHD. CV reported actuals as published; sparse fields render as —.